Page last updated: 2024-08-26

lopinavir and Pyrexia

lopinavir has been researched along with Pyrexia in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (9.09)24.3611
2020's10 (90.91)2.80

Authors

AuthorsStudies
Fang, W; Hu, Y; Huang, D; Huang, G; Huang, X; Lang, C; Li, B; Luo, Y; Lv, J; Shen, L; Sun, Q; Wan, S; Xiang, Y; Xiong, Y; Yang, H; Yang, R; Zheng, Y1
Chen, W; Ding, JG; Du, WJ; Hong, L; Luo, YL; Ruan, ZW; Sun, QF; Wang, XF; Xia, SC; Ye, XT; Zhang, WW; Zhou, Y1
Aguado, JM; Andrés, A; Delgado, JF; Fernández-Ruiz, M; Folgueira, MD; González, E; Lalueza, A; Loinaz, C; López-Medrano, F; Lumbreras, C; Polanco, N; San Juan, R1
Del Popolo, G; Righi, G1
Bai, K; Chen, H; Fu, Y; Hu, J; Li, C; Liu, C; Liu, W; Qin, Y; Xu, F; Zhang, Q1
Chen, M; Chen, Z; Gao, G; Ma, X; Qian, F; Wang, A; Wang, S; Wang, X; Yu, F; Zhang, F; Zhang, J; Zhao, T1
Gan, W; Gu, J; Li, H; Li, Y; Lu, C; Luo, P; Miao, H; Tian, M; Wang, J; Wang, S; Wu, M; Yao, Y; Yuan, B; Zhao, D; Zhao, X1
Cao, Z; Huang, K; Jiang, D; Wang, W; Xie, Y; Zheng, F; Zhou, J; Zhou, Z1
Cai, H; Dai, W; Fang, Q; Guo, Y; Lang, G; Li, L; Li, Y; Liu, J; Ni, Q; Qiu, Y; Shi, D; Su, J; Tao, J; Wang, X; Wu, W; Wu, X; Xia, Q; Xu, K; Xu, M; Xu, Y; Yi, P; Yu, L; Zhao, H; Zhou, J1
Aalipour, MA; Darazam, IA; Ghorbani, F; Pakdaman, H; Ramezani, M; Sagharichi, M; Simani, L1
Babiker, A; Fox, L; Gey, D; Lopardo, G; Markowitz, N; Paton, N; Tavel, JA; Wentworth, D; Wyman, N1

Reviews

1 review(s) available for lopinavir and Pyrexia

ArticleYear
Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020, Volume: 39, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Asymptomatic Diseases; Betacoronavirus; Biomarkers; Child; Clinical Laboratory Techniques; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Drug Combinations; Early Diagnosis; Fever; Humans; Hydroxychloroquine; Interferon-alpha; Lopinavir; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Ribavirin; Ritonavir; RNA, Viral; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed

2020

Trials

1 trial(s) available for lopinavir and Pyrexia

ArticleYear
Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study.
    PloS one, 2010, Feb-23, Volume: 5, Issue:2

    Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Carbamates; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Furans; HIV Infections; Humans; Interleukin-2; Lopinavir; Male; Nausea; Oligopeptides; Opportunistic Infections; Organophosphates; Pyridines; Pyrimidinones; Ritonavir; Sulfonamides; Treatment Outcome

2010

Other Studies

9 other study(ies) available for lopinavir and Pyrexia

ArticleYear
Clinical features and treatment of COVID-19 patients in northeast Chongqing.
    Journal of medical virology, 2020, Volume: 92, Issue:7

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Betacoronavirus; Biomarkers; Cardiovascular Diseases; China; Clinical Laboratory Techniques; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Diabetes Complications; Diabetes Mellitus; Drug Combinations; Drugs, Chinese Herbal; Fatigue; Female; Fever; Humans; Interferons; Lopinavir; Male; Middle Aged; Neoplasms; Pandemics; Pneumonia, Viral; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed

2020
Clinical efficacy of lopinavir/ritonavir in the treatment of Coronavirus disease 2019.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:6

    Topics: Adolescent; Betacoronavirus; Child; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Fever; Humans; Lopinavir; Male; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2

2020
COVID-19 in solid organ transplant recipients: A single-center case series from Spain.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020, Volume: 20, Issue:7

    Topics: Aged; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Combinations; Female; Fever; Humans; Hydroxychloroquine; Immunosuppressive Agents; Interferon-beta; Lopinavir; Male; Middle Aged; Organ Transplantation; Pandemics; Pneumonia, Viral; Radiography, Thoracic; Retrospective Studies; Ritonavir; SARS-CoV-2; Spain; Transplant Recipients

2020
COVID-19 tsunami: the first case of a spinal cord injury patient in Italy.
    Spinal cord series and cases, 2020, 04-17, Volume: 6, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Retroviral Agents; Clinical Laboratory Techniques; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Fever; Hospitalization; Humans; Italy; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Quadriplegia; Respiration, Artificial; Ritonavir; Severe acute respiratory syndrome-related coronavirus; Spinal Cord Injuries

2020
Clinical Analysis of 25 COVID-19 Infections in Children.
    The Pediatric infectious disease journal, 2020, Volume: 39, Issue:7

    Topics: Adolescent; Age Factors; Antiviral Agents; Betacoronavirus; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Child; Child, Preschool; China; Coronavirus Infections; Cough; COVID-19; Female; Fever; Humans; Infant; Lopinavir; Lymphocyte Count; Male; Pandemics; Pneumonia, Viral; Prognosis; Retrospective Studies; Ribavirin; Ritonavir; SARS-CoV-2; Treatment Outcome

2020
Brief Report: Retrospective Evaluation on the Efficacy of Lopinavir/Ritonavir and Chloroquine to Treat Nonsevere COVID-19 Patients.
    Journal of acquired immune deficiency syndromes (1999), 2020, 10-01, Volume: 85, Issue:2

    Topics: Adult; Antimalarials; Chloroquine; Chronic Disease; Coronavirus Infections; COVID-19; Drug Combinations; Female; Fever; HIV Protease Inhibitors; Humans; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; Ritonavir; Treatment Outcome; Young Adult

2020
First patient management of COVID-19 in Changsha, China: a case report.
    BMC infectious diseases, 2020, Nov-11, Volume: 20, Issue:1

    Topics: Betacoronavirus; China; Coronavirus Infections; Cough; COVID-19; COVID-19 Drug Treatment; Female; Fever; Glucocorticoids; HIV Protease Inhibitors; Humans; Interferon alpha-2; Lopinavir; Lung; Middle Aged; Pandemics; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome

2020
Clinical efficacy of methylprednisolone and the combined use of lopinavir/ritonavir with arbidol in treatment of coronavirus disease 2019.
    Journal of medical virology, 2021, Volume: 93, Issue:7

    Topics: Antiviral Agents; China; COVID-19 Drug Treatment; Drug Combinations; Female; Fever; Humans; Indoles; Length of Stay; Lopinavir; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Ritonavir; SARS-CoV-2

2021
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
    Journal of neurovirology, 2021, Volume: 27, Issue:1

    Topics: Adult; Aged; Antiviral Agents; Cough; COVID-19; COVID-19 Drug Treatment; Dementia; Drug Combinations; Dyspnea; Fatigue Syndrome, Chronic; Female; Fever; Humans; Hydroxychloroquine; Lopinavir; Male; Middle Aged; Oseltamivir; Research Design; Ritonavir; SARS-CoV-2; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Survivors

2021